Stone House Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Stone House Investment Management's AMGN Position: Q1 2026 in Review
Stone House Investment Management increased its Amgen (AMGN) stake by 5.3% in Q1 2026, buying an estimated $4.63K and bringing the position to 257 shares worth $90.5K. The position accounts for 0.02% of the portfolio, ranked #131.
Stone House Investment Management first reported a position in AMGN in Q1 2019 and has held it in 13 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Stone House Investment Management held 257 shares of Amgen worth $90.5K as of Q1 2026.
- Stone House Investment Management bought 13 Amgen shares in Q1 2026, an estimated $4.63K.
- Amgen made up 0.02% of Stone House Investment Management's portfolio in Q1 2026, its #131 holding.
- Stone House Investment Management first reported a position in Amgen in Q1 2019 and has held it in 13 quarters since.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.